Rituximab plus chemotherapy, CD34+cell selection and high-dose chemotherapy in advanced stage mantle-cell lymphoma.

被引：0
|
作者：
Martinelli, G [1 ]
Alietti, A [1 ]
Cinieri, S [1 ]
Rabascio, C [1 ]
Corsini, C [1 ]
Agazzi, A [1 ]
De Luzio, K [1 ]
Cocorcchio, E [1 ]
Ferrucci, PF [1 ]
Laszlo, D [1 ]
Bertolini, F [1 ]
机构：
[1] European Inst Oncol, Div Hematoncol, Milan, Italy
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2550
引用
收藏
页码：648A / 648A
页数：1
相关论文
共 50 条
  • [41] Treatment of follicular and mantle cell non-Hodgkin's lymphoma with anti-CD20 antibody Rituximab after high-dose chemotherapy with autologous CD34+enriched peripheral blood stem cell transplantation.
    Brugger, W
    Hirsch, J
    Repp, R
    Schlimok, G
    Grunebach, F
    Vogel, W
    Kopp, HG
    Aulitzky, W
    Ganser, A
    Gramatzki, M
    Fehnle, K
    Kanz, L
    BLOOD, 2000, 96 (11) : 482A - 483A
  • [42] High-dose chemotherapy (HDCT) with peripheral autologous stem cell transplantation (PBSCT) in patients with peripheral T-cell lymphoma.
    Reimer, P
    Braun, M
    Weissinger, F
    Rüdiger, T
    Müller-Hermelink, HK
    Wilhelm, M
    BLOOD, 2000, 96 (11) : 375B - 375B
  • [43] A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma
    Arcaini, L
    Orlandi, E
    Alessandrino, EP
    Iacona, I
    Brusamolino, E
    Bonfichi, M
    Bernasconi, P
    Calatroni, S
    Tenore, A
    Montanari, F
    Troletti, D
    Pascutto, C
    Regazzi, M
    Lazzarino, M
    BONE MARROW TRANSPLANTATION, 2004, 34 (02) : 175 - 179
  • [44] A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma
    L Arcaini
    E Orlandi
    E P Alessandrino
    I Iacona
    E Brusamolino
    M Bonfichi
    P Bernasconi
    S Calatroni
    A Tenore
    F Montanari
    D Troletti
    C Pascutto
    M Regazzi
    M Lazzarino
    Bone Marrow Transplantation, 2004, 34 : 175 - 179
  • [45] Maintenance Rituximab after High-Dose Therapy and Autologous Stem Cell Transplantation in Mantle Cell Lymphoma
    Roider, Tobias
    Dietrich, Sascha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (11) : 1811 - 1812
  • [46] Autologous stem cell transplantation (ASCT) in lymphomas:: impact of previous chemotherapy and CD34+cell dose on hematological recovery
    Martin, A
    Pérez-Simón, JA
    Caballero, MD
    López, N
    Vázquez, L
    Cañizo, MC
    García-Sanz, R
    San Miguel, JF
    BONE MARROW TRANSPLANTATION, 2002, 29 : S95 - S95
  • [47] High-dose chemotherapy (HDC) followed by autologous stem cell transplant (ASCT) for recurrent/progressive CNS lymphoma.
    Welch, Mary Roberta
    Sauter, Craig Steven
    Matasar, Matthew J.
    Moskowitz, Craig
    Omuro, Antonio Marcilio Padula
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] High dose chemotherapy with autologous stem cell transplant (ASCT) for mantle cell lymphoma (MCL).
    Segota, E
    Pohlman, B
    Jin, T
    Kuczkowski, E
    Rybicki, L
    Kalaycio, M
    Sobecks, R
    Andresen, S
    Bolwell, U
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 602S - 602S
  • [49] High-dose treatment with autologous haemopoietic progenitor cell support for large B-cell, follicular and mantle-cell lymphoma
    Rohatiner, AZS
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (03) : 467 - 480
  • [50] Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma:: an update of a prospective study
    Lefrère, F
    Delmer, A
    Levy, V
    Delarue, R
    Varet, B
    Hermine, O
    HAEMATOLOGICA, 2004, 89 (10) : 1275 - 1276
12345